New hope for dialysis patients: special grafts studied for those with no vein options left
NCT ID NCT06422871
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 100 adults with end-stage kidney disease who need long-term dialysis but have no working access sites left. Researchers are watching how well the HeRO and Super HeRO grafts perform over two years, checking for infections, blockages, and overall safety. The goal is to better understand if these devices can provide a reliable lifeline for patients who have exhausted other options.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
HeRO Graft System or Super HeRO System (medical device)
What this could lead to
If successful, this study could confirm that these grafts are a safe and effective long-term option for dialysis patients who have run out of other access choices.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove the device works better than alternatives. Results may be limited by the small number of participants and lack of a comparison group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor Scott & White Heart and Vascular Hospital - Dallas
RECRUITINGDallas, Texas, 75226, United States
-
Houston Methodist Hospital
RECRUITINGHouston, Texas, 77030, United States
-
MedStar Washington Hospital Center
RECRUITINGWashington D.C., District of Columbia, 20010, United States
-
Sarasota Memorial Health Care System
RECRUITINGSarasota, Florida, 34239, United States
-
Sentara Norfolk General Hospital
RECRUITINGNorfolk, Virginia, 23507, United States
-
University Pittsburgh Medical Center
RECRUITINGPittsburgh, Pennsylvania, 15219, United States
-
WakeMed
RECRUITINGRaleigh, North Carolina, 27610, United States